Severe ovarian hyperstimulation syndrome and gonadotropin-releasing hormone agonist trigger in patients with hypogonadotropic hypogonadism: A report of two cases

被引:0
|
作者
Gurbuz, Ali Sami [1 ]
Gode, Funda [2 ]
Kilic, Fatma [3 ]
Gurbuz, Zeynep Umay [4 ]
Deveer, Ruya [5 ]
机构
[1] Novafertil IVF Ctr, Clin Obstet & Gynecol, Konya, Turkey
[2] Bahcesir Univ, Dept Obstet & Gynecol, Fac Med, Istanbul, Turkey
[3] Necmettin Erbakan Univ, Dept Obstet & Gynecol, Fac Med, Konya, Turkey
[4] Koc Univ, Fac Med, Istanbul, Turkey
[5] Sitki Kocman Univ, Dept Obstet & Gynecol, Fac Med, Mugla, Turkey
关键词
ART; freeze-all; GnRH agonist trigger; hypogonadotropic hypogonadism; OHSS; WOMEN;
D O I
10.4274/tjod.galenos.2020.65031
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian Hyperstimulation syndrome (OHSS) is a rare condition in patients with hypogonadotropic hypogonadism. Two patients with hypogonadotropic hypogonadism are reported, a rare case of severe OHSS and a case of prevented OHSS via gonadotropin-releasing hormone (GnRH) agonist trigger, respectively. The first case was a 31-year-old patient. in vitro fertilization (IVF) treatment was performed three times but the patient never developed OHSS. The first patient was diagnosed as having severe OHSS on the ninth day after the fresh embryo transfer. She stayed 66 days in hospital and 50.5 litres of fluid were aspirated from her abdomen. The second case was a 26-year-old and primary infertile patient. She had never undergone IVF treatment. The GnRH agonist stimulation test was performed before IVF treatment. After the ovarian stimulation, GnRH agonist trigger was given. Thirty-two oocytes were retrieved from the ovaries and OHSS did not occur. Although severe OHSS is rare, it can develop in patients hypogonadotropic hypogonadism. If a GnRH stimulation test is performed before ovarian stimulation, OHSS can be prevented because the test allows agonist triggering instead of hCG in hypogonadotropic hypogonadism.
引用
收藏
页码:314 / 317
页数:4
相关论文
共 50 条
  • [31] Prevention of ovarian hyperstimulation syndrome in a rat model: comparison of the efficacy of tocilizumab with that of ranibizumab, cabergoline, and a gonadotropin-releasing hormone antagonist
    Taskin, Mine Islimye
    Topcu, Onur
    Yay, Arzu
    Erken, Gulten
    Balcioglu, Esra
    Adali, Ertan
    Hismiogullari, Adnan Adil
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (12) : 949 - 954
  • [32] Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves the outcome of intrauterine insemination
    Halim, Binarwan
    Lubis, Hilma Putri
    OBSTETRICS & GYNECOLOGY SCIENCE, 2022, 65 (02) : 207 - 214
  • [33] Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormone protocol
    Rabati, Behnaz Khani
    Zeidi, Setare Nasiri
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (11): : 1063 - 1066
  • [34] Kisspeptin-54 Accurately Identifies Hypothalamic Gonadotropin-Releasing Hormone Neuronal Dysfunction in Men with Congenital Hypogonadotropic Hypogonadism
    Abbara, Ali
    Eng, Pei Chia
    Phylactou, Maria
    Clarke, Sophie A.
    Mills, Edouard
    Chia, Germaine
    Yang, Lisa
    Izzi-Engbeaya, Chioma
    Smith, Neil
    Jayasena, Channa N.
    Comninos, Alexander N.
    Anand-Ivell, Ravinder
    Rademaker, Jesse
    Xu, Cheng
    Quinton, Richard
    Pitteloud, Nelly
    Dhillo, Waljit S.
    NEUROENDOCRINOLOGY, 2021, 111 (12) : 1176 - 1186
  • [35] A man with hypogonadotropic hypogonadism successfully treated with nasal administration of the low-dose gonadotropin-releasing hormone analog buserelin
    Iwamoto, Hideki
    Yoshida, Atsumi
    Suzuki, Hiroki
    Tanaka, Miho
    Watanabe, Noriko
    Nakamura, Takumi
    FERTILITY AND STERILITY, 2009, 92 (03) : 1169.e1 - 1169.e3
  • [36] Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin
    Ginevra Mills
    Michael H. Dahan
    Archives of Gynecology and Obstetrics, 2022, 306 : 1731 - 1737
  • [37] Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin
    Mills, Ginevra
    Dahan, Michael H.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (05) : 1731 - 1737
  • [38] Measurement of Luteinizing Hormone Level After Gonadotropin-Releasing Hormone Agonist Trigger Is Not Useful for Predicting Oocyte Maturity
    Dunne, Caitlin
    Shan, Angel
    Nakhuda, Gary
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2018, 40 (12) : 1618 - 1622
  • [39] POLYCYSTIC OVARIES IN PATIENTS WITH HYPOGONADOTROPIC HYPOGONADISM - SIMILARITY OF OVARIAN RESPONSE TO GONADOTROPIN STIMULATION IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
    SHOHAM, Z
    CONWAY, GS
    PATEL, A
    JACOBS, HS
    FERTILITY AND STERILITY, 1992, 58 (01) : 37 - 45
  • [40] Severe menses-associated hypertension successfully treated with gonadotropin-releasing hormone agonist
    Laffin, Luke J.
    Jafar, Munnam S.
    Bakris, George L.
    JOURNAL OF CLINICAL HYPERTENSION, 2017, 19 (11): : 1202 - 1203